首页 | 本学科首页   官方微博 | 高级检索  
检索        

乳腺癌中COX-2、Bax、Bcl-2的表达及熊果酸的干预作用
引用本文:徐新伟,郭玲玲,顾振纶,蒋小岗,周文轩,郭次仪.乳腺癌中COX-2、Bax、Bcl-2的表达及熊果酸的干预作用[J].苏州大学学报(自然科学版),2012,32(4):528-531,545.
作者姓名:徐新伟  郭玲玲  顾振纶  蒋小岗  周文轩  郭次仪
作者单位:徐新伟 (苏州中药研究所,江苏苏州215007) ; 郭玲玲 (苏州大学医学部病理学与病理生理学系,江苏苏州215123) ; 顾振纶 (杭州市余杭区第一人民医院病理科,浙江杭州311100) ; 蒋小岗 (苏州大学医学部病理学与病理生理学系,江苏苏州,215123) ; 周文轩 (苏州中药研究所,江苏苏州,215007) ; 郭次仪 (苏州中药研究所,江苏苏州,215007) ;
基金项目:香港保健协会科研基金资助项目
摘    要:目的研究熊果酸(UA)对人乳腺癌SK-BR-3细胞COX-2、Bax、Bcl-2 mRNA的表达的影响,结合人体乳腺癌组织凋亡相关蛋白表达检测,探讨其作用机制,为UA的临床应用提供实验依据。方法 RT-PCR技术检测SK-BR-3细胞中COX-2、Bax、Bcl-2 mRNA的表达;免疫组织化学技术检测雌激素受体(ER)(-),人表皮生长因子受体-2(HER-2)(+)的人乳腺癌组织中COX-2、Bax、Bcl-2蛋白的表达。结果 UA作用48 h后能使乳腺癌SK-BR-3细胞中COX-2、Bcl-2 mRNA表达明显减少(P〈0.05),使Bcl-2/Bax比值减小(P〈0.05),而对Bax mRNA的表达未见明显影响;COX-2、Bcl-2、Bax蛋白在ER(-),HER-2(+)的乳腺癌组织中的表达阳性率分别为86.67%(26/30),63.33%(19/30),56.67%(17/30),COX-2与Bax表达呈明显负相关(P〈0.05),与Bcl-2未见明显相关性。结论 UA可抑制COX-2、Bcl-2 mRNA表达,使Bcl-2/Bax减小;ER(-),HER-2(+)的人乳腺癌组织中COX-2中阳性表达率较高,COX-2与Bax表达呈明显负相关,与Bcl-2表达未见明显相关性。

关 键 词:熊果酸  人表皮生长因子受体2  COX-2  Bax  Bcl-2  SK-BR-3细胞

The expressions of COX-2, Bax and Bcl-2 in the tissues of breast cancer and intervention effect of ursolic acid
XU Xin-wei,GUO Ling-ling,GU Zhen-lun,JIANG Xiao-gang,ZHOU Wen-xuan,GUO Ci-yi.The expressions of COX-2, Bax and Bcl-2 in the tissues of breast cancer and intervention effect of ursolic acid[J].Suzhou University Journal of Medical Science,2012,32(4):528-531,545.
Authors:XU Xin-wei  GUO Ling-ling  GU Zhen-lun  JIANG Xiao-gang  ZHOU Wen-xuan  GUO Ci-yi
Institution:1.Suzhou Institute of Chinese Materia Medica,Jiangsu Suzhou 215007,China;2.Dept of Pathology and Pathophysiology,Medical College,Soochow University,Jiangsu Suzhou 215123,China;3.Dept of Pathology,the First Hospital of Yuhang,Zhejiang Hangzhou 311100,China)
Abstract:Objective To investigate the expressions of COX-2,Bcl-2 and Bax mRNA in human breast cancer SK-BR-3 cells after incubation with UA and to dedect the expression of apoptosis-related proteins in the tissue of breast cancer,and to provide a reliable experimental basis for clinical applicaton of UA.Methods The expressions of COX-2,Bcl-2 and Bax mRNA in SK-BR-3 cells were determined by RT-PCR;The expressions of COX-2,Bcl-2 and Bax protein in estrogen receptor(ER)-negative and human epidermal growth-factor 2(HER2) positivity human breast cancer were determined by immunohistochemistry.Results The expression of COX-2 and Bcl-2 mRNA of SK-BR-3 cells treated by UA for 48 h decreased(P〈0.05),Bcl-2 / Bax reduced(P〈0.05),whereas the expression of Bax mRNA unchanged;The positivvity rate of COX-2、Bcl-2、Bax protein in estrogen receptor-negative and human epidermal growth-factor 2 positive breast cancer were 86.67%(26/30),63.33%(19/30) and 56.67%(17/30),respectively.The expression of COX-2 and Bax was negatively correlated(P〈0.05),whereas the expression of COX-2 and Bcl-2 was no significant correlation.Conclusion UA inhibites COX-2 and Bcl-2 mRNA expression and reduces the ratio of Bcl-2 / Bax;There is a higher positive expression of COX-2 in estrogen receptor-negative and human epidermal growth-factor 2 positive human breast cancer;The expression of COX-2 and Bax is negatively correlated,whereas the expression of COX-2 and Bcl-2 is no significant correlation.
Keywords:ursolic acid  human epidermal growth factor receptor-2  COX-2  Bax  Bcl-2  SK-BR-3 cells
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号